Oxford textbook of critical care

書誌事項

Oxford textbook of critical care

edited by Andrew R. Webb ... [et al.]

(Oxford medical publications)

Oxford University Press, 2016

2nd ed

タイトル別名

Critical care

Textbook of critical care

大学図書館所蔵 件 / 10

この図書・雑誌をさがす

注記

Includes bibliographical references and index

内容説明・目次

内容説明

The thoroughly revised second edition of the Oxford Textbook of Critical Care is a comprehensive multi-disciplinary text covering all aspects of adult intensive care management. Uniquely the book takes a problem-orientated approach providing a reference source for clinical issues experienced every day in the intensive care unit. The text is organized into short topics allowing readers to rapidly access authoritative information on specific clinical problems. Each topic refers to basic physiological principles and provides up-to-date treatment advice supported by references to the most vital literature. Where international differences exist in clinical practice, authors cover alternative views. Key messages summarise each topic in order to aid quick review and decision making. Edited and written by an international group of recognized experts from many disciplines, the second edition of the Oxford Textbook of Critical Care provides an up-to-date reference that is relevant for intensive care units and emergency departments globally. This volume is the definitive text for all health care providers, including physicians, nurses, respiratory therapists, and other allied health professionals who take care of critically ill patients. This print edition of The Oxford Textbook of Critical Care comes with a year's access to the online version on Oxford Medicine Online. By activating your unique access code, you can read and annotate the full text online, follow links from the references to primary research materials, and view, enlarge and download all the figures and tables.

目次

  • SECTION 1: ICU ORGANISATION AND MANAGEMENT: THE INTENSIVE CARE UNIT
  • PART 1.1: THE INTENSIVE CARE UNIT
  • PART 1.2: COMMUNICATION
  • PART 1.3: TRAINING
  • PART 1.4: SAFETY AND QUALITY
  • PART 1.5: GOVERNANCE
  • PART 1.6: RESEARCH
  • PART 1.7: MEDICO-LEGAL AND ETHICAL ISSUES
  • PART 1.8: CRITICAL ILLNESS RISK PREDICTION
  • SECTION 2: PHARMACOTHERAPEUTICS
  • PART 2.1: RESPIRATORY DRUGS
  • PART 2.2: CARDIOVASCULAR DRUGS
  • PART 2.3: GASTROINTESTINAL DRUGS
  • PART 2.4: NERVOUS SYSTEM DRUGS
  • PART 2.5: HORMONAL DRUGS
  • PART 2.6: HEMATOLOGICAL DRUGS
  • PART 2.7: ANTIMICROBIAL AND IMMUNOLOGICAL DRUGS
  • PART 2.8: FLUIDS AND DIURETICS
  • SECTION 3: RESUSCITATION
  • PART 3.1: RESPIRATORY MANAGEMENT
  • PART 3.2 CIRCULATORY MANAGEMENT
  • PART 3.3: FLUID MANAGEMENT
  • SECTION 4: THE RESPIRATORY SYSTEM
  • PART 4.1: PHYSIOLOGY
  • PART 4: THE RESPIRATORY SYSTEM: RESPIRATORY MONITORING
  • PART 4.2: UPPER AIRWAY OBSTRUCTION
  • PART 4.3: AIRWAY ACCESS
  • PART 4.4: ACUTE RESPIRATORY FAILURE
  • PART 4.5: VENTILATORY SUPPORT
  • PART 4.6: WEANING VENTILATORY SUPPORT
  • PART 4.7: EXTRACORPOREAL SUPPORT
  • PART 4.8: ASPIRATION AND INHALATION
  • PART 4.8: ACUTE RESPIRATORY DISTRESS SYNDROME
  • PART 4.9: AIRFLOW LIMITATION
  • PART 4.10: RESPIRATORY ACIDOSIS AND ALKALOSIS
  • PART 4.11: PNEUMONIA
  • PART 4.12: ATELECTASIS AND SPUTUM RETENTION
  • PART 4.13: PLEURAL CAVITY PROBLEMS
  • PART 4.14: HEMOPTYSIS
  • SECTION 5: THE CARDIOVASCULAR SYSTEM
  • PART 5.1: PHYSIOLOGY
  • PART 5.2: CARDIOVASCULAR MONITORING
  • PART 5.3: ACUTE CHEST PAIN AND CORONARY SYNDROMES
  • PART 5.4: AORTIC DISSECTION
  • PART 5.5: THE HYPOTENSIVE PATIENT
  • PART 5.6: CARDIAC FAILURE
  • PART 5.7: TACHYARRHYTHMIAS
  • PART 5.8: BRADYARRHYTHMIAS
  • PART 5.9: VALVULAR PROBLEMS
  • PART 5.10: ENDOCARDITIS
  • PART 5.11: SEVERE HYPERTENSION
  • PART 5.12: SEVERE CAPILLARY LEAK
  • PART 5.13: PERICARDIAL TAMPONADE
  • PART 5.14: PULMONARY HYPERTENSION
  • PART 5.15: PULMONARY EMBOLUS
  • SECTION 6: THE GASTROINTESTINAL SYSTEM
  • PART 6.1: PHYSIOLOGY
  • PART 6.2: GASTROINTESTINAL MONITORING
  • PART 6.3: GASTROINTESTINAL HEMORRHAGE
  • PART 6.4: DISORDERED GASTRIC MOTILITY
  • PART 6.5: THE ACUTE ABDOMEN IN THE ICU
  • PART 6.6: PANCREATITIS
  • PART 6.7: JAUNDICE
  • PART 6.8: ACUTE HEPATIC FAILURE
  • PART 6.9: ACUTE ON CHRONIC HEPATIC FAILURE
  • SECTION 7: NUTRITION
  • PART 7.1: PHYSIOLOGY
  • PART 7.2: NUTRITIONAL FAILURE
  • SECTION 8: THE RENAL SYSTEM
  • PART 8.1: PHYSIOLOGY
  • PART 8.2: RENAL MONITORING AND RISK PREDICTION
  • PART 8.3: OLIGURIA AND ACUTE KIDNEY INJURY
  • PART 8.4: RENAL REPLACEMENT TECHNIQUES
  • PART 8.5: ESTABLISHED RENAL FAILURE
  • SECTION 9: THE NEUROLOGICAL SYSTEM
  • PART 9.1: ANATOMY AND PHYSIOLOGY
  • PART 9.2: NEUROLOGICAL MONITORING
  • PART 9.3:SLEEP DISTURBANCE
  • PART 9.4: AGITATION, CONFUSION AND DELIRIUM
  • PART 9 THE NEUROLOGICAL SYSTEM:THE UNCONSCIOUS PATIENT
  • PART 9.5: SEIZURES
  • PART 9.6: INTRACRANIAL HYPERTENSION
  • PART 9 THE NEUROLOGICAL SYSTEM: STROKE
  • PART 9.7: NON-TRAUMATIC SUBARACHNOID HEMORRHAGE
  • PART 9.8:MENINGITIS AND ENCEPHALITIS
  • PART 9.9: NON-TRAUMATIC SPINAL INJURY
  • PART 9 THE NEUROLOGICAL SYSTEM: NEUROMUSCULAR SYNDROMES
  • SECTION 10: THE METABOLIC AND ENDOCRINE SYSTEMS
  • PART 10.1: PHYSIOLOGY
  • PART 10.2: ELECTROLYTE DISTURBANCE
  • PART 10.3: METABOLIC ACIDOSIS AND ALKALOSIS
  • PART 10.4: BLOOD GLUCOSE CONTROL
  • PART 10.5: ENDOCRINE DISORDERS
  • SECTION 11: THE HEMATOLOGICAL SYSTEM
  • PART 11.1: LABORATORY MONITORING
  • PART 11.2: HEMATOLOGICAL THERAPIES
  • PART 11.3: DISORDERED COAGULATION
  • PART 11.4: DISORDERS OF THE BLOOD CELLS
  • SECTION 12: THE SKIN AND CONNECTIVE TISSUE
  • PART 12.1: SKIN AND CONNECTIVE TISSUE DISORDERS
  • PART 12.2: WOUND AND PRESSURE SORE MANAGEMENT
  • SECTION 13: INFECTION
  • PART 13.1: DIAGNOSIS AND SURVEILLANCE
  • PART 13.2: NOSOCOMIAL INFECTION
  • PART 13.3: INFECTION IN THE IMMUNOCOMPROMISED
  • PART 13.4: TROPICAL DISEASES
  • PART 13.5: SEPSIS
  • SECTION 14: INFLAMMATION
  • PART 14.1: PHYSIOLOGY
  • PART 14.2: ORGAN-SPECIFIC BIOMARKERS
  • PART 14.3: HOST RESPONSE
  • PART 14.4: ANAPHYLAXIS
  • SECTION 15: POISONING
  • PART 15.1: PRINCIPLES OF MANAGEMENT
  • PART 15.2: MANAGEMENT OF SPECIFIC POISONS
  • SECTION 16: TRAUMA
  • PART 16.1: MULTIPLE TRAUMA
  • PART 16.2: BALLISTIC TRAUMA
  • PART 16.3: TRAUMATIC BRAIN INJURY
  • PART 16.4 SPINAL CORD INJURY
  • PART 16.5: BURNS
  • SECTION 17: PHYSICAL DISORDERS PART 17.1: DROWNING
  • PART 17.2: ELECTROCOUTION
  • PART 17.3: ALTITUDE- AND DEPTH-RELATED DISORDERS
  • PART 17.4: RHABDOMYOLYSIS
  • SECTION 18: PAIN AND SEDATION
  • PART 18.1: PAIN
  • PART 18.2: SEDATION
  • SECTION 19: GENERAL SURGICAL AND OBSTETRIC INTENSIVE CARE
  • PART 19.1: OPTIMISATION STRATEGIES FOR THE HIGH-RISK SURGICAL PATIENT
  • PART 19.2: GENERAL POST-OPERATIVE INTENSIVE CARE
  • PART 19.3: OBSTETRIC INTENSIVE CARE
  • SECTION 20: SPECIALIZED INTENSIVE CARE
  • PART 20.1: SPECIALIZED SURGICAL INTENSIVE CARE
  • PART 20.2: ONCOLOGICAL INTENSIVE CARE
  • SECTION 21: RECOVERY FROM CRITICAL ILLNESS
  • PART 21.1: IN HOSPITAL RECOVERY FROM CRITICAL ILLNESS
  • PART 21.2: COMPLICATIONS OF CRITICAL ILLNESS
  • PART 21.3: OUT OF HOSPITAL SUPPORT AFTER CRITICAL ILLNESS
  • SECTION 22: END OF LIFE CARE
  • PART 22.1: WITHDRAWING AND WITHHOLDING TREATMENT
  • PART 22.2: MANAGEMENT OF THE POTENTIAL ORGAN DONOR
  • PART 22.3: POST-MORTEM DIAGNOSIS

「Nielsen BookData」 より

関連文献: 1件中  1-1を表示

詳細情報

ページトップへ